Abstract
Glioblastoma (GBM) developed metastases rarely and the prognosis, in these cases, was very poor. We reported a 30-year patient who, developing intramedullary and leptomeningeal metastases from GBM, underwent palliative spinal radiotherapy (RT) and Bevacizumab.
Original language | English |
---|---|
Pages (from-to) | 691-694 |
Number of pages | 4 |
Journal | International Journal of Neuroscience |
Volume | 122 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2012 |
Keywords
- Bevacizumab
- Glioblastoma
- Metastases
- Radiotherapy
ASJC Scopus subject areas
- Neuroscience(all)